Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Two Small-Cap Stocks to Trade Considerably Higher in February: XPO Logistics Inc (XPO), Sarepta Therapeutics Inc (SRPT)

The company will meet with the FDA to discuss an accelerated approval, and most analysts are optimistic that the drug will hit shelves soon. The stock is priced at $27.80, down from its $45.00 October high, and I anticipate a move higher to the mid-high $30s by the end of February. Right now, the stock has price targets from $54 to $83 based on price/peak sales between 2 and 3. However, I tend to believe that if approved and if commercially successful that Sarepta will enjoy the same value/revenue metrics that are seen in stocks such as Alexion Pharmaceuticals, Regeneron Pharmaceuticals, and BioMarin Pharmaceuticals at or around 10x sales. Therefore, if Sarepta’s drug is approved, reaches annual sales of $500 million within three years, and finds a partnership for global development, then prices near $200 are not out of the question, if all pieces fall into place.

Conclusion

In my opinion, both of these two stocks are greatly undervalued. Sarepta has one of the best technologies in biotechnology and if the FDA meeting goes well then gains won’t be far behind, neither will large pharma. XPO Logistics is the best kept secret on Wall Street, although soon it will be realized. I urge investors to take time and research both stocks to see if either fits into your portfolio. At that point you can make an educated decision, and will most likely see the clear upside in shares of these two stocks.

The article Two Small-Cap Stocks to Trade Considerably Higher in February originally appeared on Fool.com and is written by Brian Nichols.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.